Raymond James & Associates Charles River Laboratories International, Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 249,037 shares of CRL stock, worth $41.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
249,037
Previous 248,112 0.37%
Holding current value
$41.1 Million
Previous $51.3 Million 4.29%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$187.96 - $245.29 $173,863 - $226,893
925 Added 0.37%
249,037 $49.1 Million
Q2 2024

Jul 19, 2024
SELL
$206.39 - $268.73 $48,708 - $63,420
-236 Reduced 0.1%
248,112 $51.3 Million
Q1 2024

Apr 22, 2024
BUY
$203.52 - $273.43 $948,403 - $1.27 Million
4,660 Added 1.91%
248,348 $67.3 Million
Q4 2023

Jan 16, 2024
SELL
$164.52 - $238.84 $1.4 Million - $2.03 Million
-8,488 Reduced 3.37%
243,688 $57.6 Million
Q3 2023

Oct 24, 2023
BUY
$194.44 - $217.61 $1.17 Million - $1.31 Million
6,013 Added 2.44%
252,176 $49.4 Million
Q2 2023

Jul 25, 2023
BUY
$183.71 - $210.25 $2.53 Million - $2.9 Million
13,793 Added 5.94%
246,163 $51.8 Million
Q1 2023

Apr 14, 2023
BUY
$191.89 - $259.92 $1.66 Million - $2.25 Million
8,653 Added 3.87%
232,370 $46.9 Million
Q4 2022

Feb 08, 2023
SELL
$197.11 - $250.07 $1.53 Million - $1.95 Million
-7,786 Reduced 3.36%
223,717 $48.7 Million
Q3 2022

Oct 25, 2022
BUY
$182.44 - $250.54 $19.5 Million - $26.8 Million
107,047 Added 86.01%
231,503 $45.6 Million
Q2 2022

Aug 12, 2022
BUY
$204.13 - $302.4 $1.79 Million - $2.66 Million
8,783 Added 7.59%
124,456 $26.6 Million
Q1 2022

May 11, 2022
SELL
$255.51 - $362.11 $25.1 Million - $35.5 Million
-98,062 Reduced 45.88%
115,673 $32.8 Million
Q4 2021

Feb 08, 2022
BUY
$351.38 - $448.68 $11.8 Million - $15.1 Million
33,607 Added 18.66%
213,735 $80.5 Million
Q3 2021

Nov 02, 2021
BUY
$372.64 - $458.3 $3.23 Million - $3.97 Million
8,670 Added 5.06%
180,128 $74.3 Million
Q2 2021

Aug 11, 2021
BUY
$294.17 - $371.65 $3.33 Million - $4.21 Million
11,332 Added 7.08%
171,458 $63.4 Million
Q1 2021

May 14, 2021
BUY
$249.67 - $299.48 $7.55 Million - $9.05 Million
30,229 Added 23.27%
160,126 $46.4 Million
Q4 2020

Feb 12, 2021
BUY
$222.0 - $252.62 $5.07 Million - $5.76 Million
22,817 Added 21.31%
129,897 $32.5 Million
Q3 2020

Nov 04, 2020
BUY
$175.56 - $226.45 $2.41 Million - $3.11 Million
13,745 Added 14.73%
107,080 $24.2 Million
Q2 2020

Jul 28, 2020
BUY
$118.84 - $189.72 $1.47 Million - $2.34 Million
12,352 Added 15.25%
93,335 $16.3 Million
Q1 2020

Apr 21, 2020
BUY
$98.9 - $178.34 $587,169 - $1.06 Million
5,937 Added 7.91%
80,983 $10.2 Million
Q4 2019

Feb 12, 2020
BUY
$126.05 - $152.76 $604,409 - $732,484
4,795 Added 6.83%
75,046 $11.5 Million
Q3 2019

Nov 07, 2019
BUY
$125.07 - $143.67 $1.56 Million - $1.79 Million
12,466 Added 21.57%
70,251 $9.3 Million
Q2 2019

Aug 06, 2019
BUY
$123.4 - $148.55 $2.39 Million - $2.88 Million
19,387 Added 50.49%
57,785 $8.2 Million
Q1 2019

May 06, 2019
BUY
$104.82 - $146.73 $642,861 - $899,895
6,133 Added 19.01%
38,398 $5.58 Million
Q4 2018

Feb 11, 2019
BUY
$105.09 - $137.23 $117,070 - $152,874
1,114 Added 3.58%
32,265 $3.65 Million
Q3 2018

Nov 14, 2018
BUY
$112.11 - $134.54 $3.49 Million - $4.19 Million
31,151 New
31,151 $4.19 Million
Q1 2018

May 14, 2018
SELL
$98.19 - $115.2 $476,025 - $558,489
-4,848 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$100.43 - $118.09 $82,955 - $97,542
826 Added 20.54%
4,848 $531,000
Q3 2017

Nov 13, 2017
BUY
$96.72 - $109.26 $27,855 - $31,466
288 Added 7.71%
4,022 $434,000
Q2 2017

Aug 14, 2017
BUY
N/A
3,734
3,734 $378,000

Others Institutions Holding CRL

# of Institutions
691
Shares Held
52M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.39B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email